Jang MH, Ahn J-M, Kang D-Y, Kim KW, Koo HJ, Yang DH, et al. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement. Heart. 2024;110(2):140–7.
Makkar RR, Blanke P, Leipsic J, Thourani V, Chakravarty T, Brown D, et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy. J Am Coll Cardiol. 2020;75(24):3003–15.
Goel K, Lindman BR. Hypoattenuated leaflet thickening after transcatheter aortic valve replacement. Circ Cardiovasc Imaging. 2019;12(12):e010151.
Nicolas J, Dangas G. Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement: Additional Data, Yet Still Many Unanswered Questions. Circulation: Cardiovascular Interventions. 2022;15(3):e011828.
Jilaihawi H, Asch FM, Manasse E, Ruiz CE, Jelnin V, Kashif M, et al. Systematic CT methodology for the evaluation of subclinical leaflet thrombosis. JACC: Cardiovasc Imaging. 2017;10(4):461–70.
Samadzadeh Tabrizi N, Fishberger G, Musuku SR, Shapeton AD. Hypoattenuated leaflet thickening: A comprehensive review of contemporary data. J Cardiothorac Vasc Anesth. 2024;38(11):2761–9.
Sondergaard L, De Backer O, Kofoed KF, Jilaihawi H, Fuchs A, Chakravarty T, et al. Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves. Eur Heart J. 2017;38(28):2201–7.
Article PubMed CAS Google Scholar
Garcia S, Fukui M, Dworak MW, Okeson BK, Garberich R, Hashimoto G, et al. Clinical impact of hypoattenuating leaflet thickening after transcatheter aortic valve replacement. Circulation: Cardiovasc Interventions. 2022;15(3):e011480.
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter Aortic-Valve replacement with a Balloon-Expandable valve in Low-Risk patients. N Engl J Med. 2019;380(18):1695–705.
Makkar RR, Cheng W, Waksman R, Satler LF, Chakravarty T, Groh M, et al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet. 2020;396(10252):669–83.
Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373(21):2015–24.
Article PubMed CAS Google Scholar
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter Aortic-Valve replacement with a Self-Expanding valve in Low-Risk patients. N Engl J Med. 2019;380(18):1706–15.
Thyregod HG, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-Year results from the All-Comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65(20):2184–94.
Pandya PK, Park MH, Zhu Y, Woo YJ. Biomechanical analysis of novel leaflet geometries for bioprosthetic valves. JTCVS Open. 2023;14:77–86.
Article PubMed PubMed Central Google Scholar
Case BC, Khan JM, Rogers T. Early leaflet thickening, durability and bioprosthetic valve failure in TAVR. Interv Cardiol Clin. 2021;10(4):531–9.
PubMed PubMed Central Google Scholar
Hosadurg N, Patel TR, Villines TC. Hypoattenuated leaflet thickening in a tendyne bioprosthetic mitral valve. JACC Cardiovasc Interv. 2022;15(17):e193–4.
Article PubMed PubMed Central Google Scholar
Dangas GD, Weitz JI, Giustino G, Makkar R, Mehran R. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68(24):2670–89.
Ng ACT, Holmes DR, Mack MJ, Delgado V, Makkar R, Blanke P, et al. Leaflet immobility and thrombosis in transcatheter aortic valve replacement. Eur Heart J. 2020;41(33):3184–97.
Article PubMed PubMed Central CAS Google Scholar
Ducci A, Tzamtzis S, Mullen MJ, Burriesci G. Hemodynamics in the Valsalva sinuses after transcatheter aortic valve implantation (TAVI). J Heart Valve Dis. 2013;22(5):688–96.
Brown RA, Reid AB, Turaga M, Huang AL, Maggiore PL, Sellers SL, et al. Subclinical leaflet thrombosis post transcatheter aortic valve Replacement– An update for 2020. Struct Heart. 2020;4(5):369–81.
Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, et al. Transcatheter aortic valve replacement in Low-Risk patients with symptomatic severe aortic stenosis. J Am Coll Cardiol. 2018;72(18):2095–105.
Marro M, Kossar AP, Xue Y, Frasca A, Levy RJ, Ferrari G. Noncalcific mechanisms of bioprosthetic structural valve degeneration. J Am Heart Assoc. 2021;10(3):e018921.
Article PubMed PubMed Central CAS Google Scholar
Tarantini G, Sathananthan J, Fabris T, Landes U, Bapat VN, Khan JM, et al. Transcatheter aortic valve replacement in failed transcatheter bioprosthetic valves. JACC Cardiovasc Interv. 2022;15(18):1777–93.
Hein M, Schoechlin S, Schulz U, Minners J, Breitbart P, Lehane C, et al. Long-Term Follow-Up of hypoattenuated leaflet thickening after transcatheter aortic valve replacement. JACC: Cardiovasc Interventions. 2022;15(11):1113–22.
Rashid HN, Rajani R, Leipsic J, Maurovitch-Horvat P, Patterson T, Redwood S, et al. Computed tomography imaging for subclinical leaflet thrombosis following surgical and transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2023;17(1):2–10.
Khav N, Rashid HN, Brown AJ. The role of four-dimensional computed tomography in transcatheter aortic valve replacement prosthesis endocarditis with concurrent leaflet thrombosis: a case report. Eur Heart J - Case Rep. 2020;4(5):1–5.
Article PubMed PubMed Central Google Scholar
Passaniti G, Prandi FR, Sharma S, Kini A, Lerakis S. Echo HALT: do we really need a cardiac CT? Int J Cardiovasc Imaging. 2024;40(1):81–2.
Abdel-Wahab M, Simonato M, Latib A, Goleski PJ, Allali A, Kaur J, et al. Clinical valve thrombosis after transcatheter aortic valve-in-Valve implantation. Circ Cardiovasc Interv. 2018;11(11):e006730.
Del Trigo M, Muñoz-Garcia AJ, Wijeysundera HC, Nombela-Franco L, Cheema AN, Gutierrez E, et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol. 2016;67(6):644–55.
Franzone A, Pilgrim T, Haynes AG, Lanz J, Asami M, Praz F, et al. Transcatheter aortic valve thrombosis: incidence, clinical presentation and long-term outcomes. Eur Heart J Cardiovasc Imaging. 2018;19(4):398–404.
Jose J, Sulimov DS, El-Mawardy M, Sato T, Allali A, Holy EW, et al. Clinical bioprosthetic heart valve thrombosis after transcatheter aortic valve replacement: incidence, characteristics, and treatment outcomes. JACC Cardiovasc Interv. 2017;10(7):686–97.
Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8(4).
Overtchouk P, Guedeney P, Rouanet S, Verhoye JP, Lefevre T, Van Belle E, et al. Long-Term mortality and early valve dysfunction according to anticoagulation use: the FRANCE TAVI registry. J Am Coll Cardiol. 2019;73(1):13–21.
Reardon MJ, Feldman TE, Meduri CU, Makkar RR, O’Hair D, Linke A, et al. Two-Year outcomes after transcatheter aortic valve replacement with mechanical vs Self-expanding valves: the REPRISE III randomized clinical trial. JAMA Cardiol. 2019;4(3):223–9.
Article PubMed PubMed Central Google Scholar
Spartera M, Ancona F, Barletta M, Rosa I, Stella S, Marini C, et al. Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis. Echocardiography. 2018;35(3):337–45.
Vollema EM, Kong WKF, Katsanos S, Kamperidis V, van Rosendael PJ, van der Kley F, et al. Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke. Eur Heart J. 2017;38(16):1207–17.
Comments (0)